171 related articles for article (PubMed ID: 32580635)
1. Double-Stranded Structure of the Polyinosinic-Polycytidylic Acid Molecule to Elicit TLR3 Signaling and Adjuvant Activity in Murine Intranasal A(H1N1)pdm09 Influenza Vaccination.
Nakano T; Ohara Y; Fujita H; Ainai A; Yamamura ET; Suzuki T; Hasegawa H; Sone T; Asano K
DNA Cell Biol; 2020 Sep; 39(9):1730-1740. PubMed ID: 32580635
[TBL] [Abstract][Full Text] [Related]
2. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
[TBL] [Abstract][Full Text] [Related]
3. Combined Intranasal Nanoemulsion and RIG-I Activating RNA Adjuvants Enhance Mucosal, Humoral, and Cellular Immunity to Influenza Virus.
Wong PT; Goff PH; Sun RJ; Ruge MJ; Ermler ME; Sebring A; O'Konek JJ; Landers JJ; Janczak KW; Sun W; Baker JR
Mol Pharm; 2021 Feb; 18(2):679-698. PubMed ID: 32491861
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 3 in nasal CD103
Takaki H; Kure S; Oshiumi H; Sakoda Y; Suzuki T; Ainai A; Hasegawa H; Matsumoto M; Seya T
Mucosal Immunol; 2018 Jan; 11(1):82-96. PubMed ID: 28612840
[TBL] [Abstract][Full Text] [Related]
5. Consecutive inoculations of influenza virus vaccine and poly(I:C) protects mice against homologous and heterologous virus challenge.
Moriyama M; Chino S; Ichinohe T
Vaccine; 2017 Feb; 35(7):1001-1007. PubMed ID: 28111142
[TBL] [Abstract][Full Text] [Related]
6. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
[TBL] [Abstract][Full Text] [Related]
7. Induction of lung CD8
Moriyama M; Takeyama H; Hasegawa H; Ichinohe T
Vaccine; 2017 Dec; 35(48 Pt B):6620-6626. PubMed ID: 29079103
[TBL] [Abstract][Full Text] [Related]
8. Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity.
Kulkarni RR; Rasheed MA; Bhaumik SK; Ranjan P; Cao W; Davis C; Marisetti K; Thomas S; Gangappa S; Sambhara S; Murali-Krishna K
J Virol; 2014 Dec; 88(24):13990-4001. PubMed ID: 25253340
[TBL] [Abstract][Full Text] [Related]
9. Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection.
Asahi-Ozaki Y; Itamura S; Ichinohe T; Strong P; Tamura S; Takahashi H; Sawa H; Moriyama M; Tashiro M; Sata T; Kurata T; Hasegawa H
Microbes Infect; 2006 Oct; 8(12-13):2706-14. PubMed ID: 16968669
[TBL] [Abstract][Full Text] [Related]
10. Vaccine adjuvant ARNAX promotes mucosal IgA production in influenza HA vaccination.
Takeda Y; Takaki H; Fukui-Miyazaki A; Yoshida S; Matsumoto M; Seya T
Biochem Biophys Res Commun; 2018 Dec; 506(4):1019-1025. PubMed ID: 30404733
[TBL] [Abstract][Full Text] [Related]
11. Inactivated Eyedrop Influenza Vaccine Adjuvanted with Poly(I:C) Is Safe and Effective for Inducing Protective Systemic and Mucosal Immunity.
Kim ED; Han SJ; Byun YH; Yoon SC; Choi KS; Seong BL; Seo KY
PLoS One; 2015; 10(9):e0137608. PubMed ID: 26355295
[TBL] [Abstract][Full Text] [Related]
12. A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung.
Neuhaus V; Chichester JA; Ebensen T; Schwarz K; Hartman CE; Shoji Y; Guzmán CA; Yusibov V; Sewald K; Braun A
Vaccine; 2014 May; 32(26):3216-22. PubMed ID: 24731807
[TBL] [Abstract][Full Text] [Related]
13. Intranasal vaccination of recombinant H5N1 HA1 proteins fused with foldon and Fc induces strong mucosal immune responses with neutralizing activity: Implication for developing novel mucosal influenza vaccines.
Yu F; Li Y; Guo Y; Wang L; Yang J; Zhao G; Zhou Y; Du L; Jiang S
Hum Vaccin Immunother; 2015; 11(12):2831-8. PubMed ID: 26260706
[TBL] [Abstract][Full Text] [Related]
14. Zymosan enhances the mucosal adjuvant activity of poly(I:C) in a nasal influenza vaccine.
Ainai A; Ichinohe T; Tamura S; Kurata T; Sata T; Tashiro M; Hasegawa H
J Med Virol; 2010 Mar; 82(3):476-84. PubMed ID: 20087927
[TBL] [Abstract][Full Text] [Related]
15. Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus.
Moon HJ; Lee JS; Talactac MR; Chowdhury MY; Kim JH; Park ME; Choi YK; Sung MH; Kim CJ
Vet Microbiol; 2012 Dec; 160(3-4):277-89. PubMed ID: 22763171
[TBL] [Abstract][Full Text] [Related]
16. Mucosal polyinosinic-polycytidylic acid improves protection elicited by replicating influenza vaccines via enhanced dendritic cell function and T cell immunity.
Pérez-Girón JV; Belicha-Villanueva A; Hassan E; Gómez-Medina S; Cruz JL; Lüdtke A; Ruibal P; Albrecht RA; García-Sastre A; Muñoz-Fontela C
J Immunol; 2014 Aug; 193(3):1324-32. PubMed ID: 24958904
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
Gupta NK; Tomar P; Sharma V; Dixit VK
Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
[TBL] [Abstract][Full Text] [Related]
18. Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.
Thomas M; Wang Z; Sreenivasan CC; Hause BM; Gourapura J Renukaradhya ; Li F; Francis DH; Kaushik RS; Khatri M
Vaccine; 2015 Jan; 33(4):542-8. PubMed ID: 25437101
[TBL] [Abstract][Full Text] [Related]
19. TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection.
Jelinek I; Leonard JN; Price GE; Brown KN; Meyer-Manlapat A; Goldsmith PK; Wang Y; Venzon D; Epstein SL; Segal DM
J Immunol; 2011 Feb; 186(4):2422-9. PubMed ID: 21242525
[TBL] [Abstract][Full Text] [Related]
20. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.
Ichinohe T; Ainai A; Nakamura T; Akiyama Y; Maeyama J; Odagiri T; Tashiro M; Takahashi H; Sawa H; Tamura S; Chiba J; Kurata T; Sata T; Hasegawa H
J Med Virol; 2010 Jan; 82(1):128-37. PubMed ID: 19950232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
